Exhibit 10.01


 


SHARE EXCHANGE AGREEMENT


  


by and
among


 


H/Cell Energy Corporation (“H/Cell”),


a Nevada
corporation


 


on
the one hand;


 


and


 


The Pride Group (Qld) Pty Ltd. (“Pride”),


an Australian
corporation


 


and


 


the Shareholders of Pride


 


on
the other hand


 


January
31, 2017


 




     


     


    

 


Table
of Contents


 


	 	 	Page
	 	 	 
	ARTICLE I     Exchange of Shares; Closing	 
	 	 	 
	Section 1.01.	Exchange of Shares; NTAV Adjustment	1
	 	 	 
	Section 1.02.	Closing Date	3
	 	 	 
	Section 1.03.	Transactions to be Effected at the Closing	3
	 	 	 
	ARTICLE II     Representations and Warranties of the Pride Shareholders	 
	 	 	 
	Section 2.01.	Organization	4
	 	 	 
	Section 2.02.	Capitalization	4
	 	 	 
	Section 2.03.	Authority; Execution and Delivery; Enforceability	4
	 	 	 
	Section 2.04.	Title to Shares	5
	 	 	 
	Section 2.05.	Acquisition Shares for Investment Purposes	5
	 	 	 
	Section 2.06.	Accredited Investor Status	6
	 	 	 
	Section 2.07.	No Conflicts; Consents	6
	 	 	 
	Section 2.08.	Financial Information	6
	 	 	 
	Section 2.09.	Absence of Changes	7
	 	 	 
	Section 2.10.	No Undisclosed Liabilities	7
	 	 	 
	Section 2.11.	Litigation	7
	 	 	 
	Section 2.12.	Condition of Assets	7
	 	 	 
	Section 2.13.	Compliance with Laws; Permits	8
	 	 	 
	Section 2.14.	Tax Matters	8
	 	 	 
	Section 2.15.	Labor and Employee Benefit Matters	8
	 	 	 
	Section 2.16.	Real Property	9
	 	 	 
	Section 2.17.	Environmental	9
	 	 	 
	Section 2.18.	Contracts	10
	 	 	 
	Section 2.19.	Intellectual Property	10
	 	 	 
	Section 2.20.	Brokers and Finders	10
	 	 	 
	Section 2.21.	Disclosure	10
	 	 	 
	Section 2.22.	Disclaimer of Other Representations and Warranties	10
	 	 	 
	ARTICLE III     Representations and Warranties of H/Cell	 
	 	 	 
	Section 3.01.	Organization	11
	 	 	 
	Section 3.02.	Authority; Execution and Delivery; Enforceability	11


 




    - i -


     


    

 


Table
of Contents


(continued)


 


	 	 	Page
	 	 	 
	Section 3.03.	No Conflicts; Consents	11
	 	 	 
	Section 3.04.	Investment Representation	12
	 	 	 
	Section 3.05.	Brokers and Finders	12
	 	 	 
	ARTICLE IV     Covenants	 
	 	 	 
	Section 4.01.	Access and Investigation	12
	 	 	 
	Section 4.02.	Negative Covenant	12
	 	 	 
	Section 4.03.	Required Approvals	12
	 	 	 
	Section 4.04.	Retention of Books and Records	13
	 	 	 
	Section 4.05.	Expenses; Transfer Taxes	13
	 	 	 
	Section 4.06.	Post-Closing Cooperation	13
	 	 	 
	Section 4.07.	Publicity	13
	 	 	 
	Section 4.08.	Further Assurances	14
	 	 	 
	Section 4.09.	Survival and Right to Indemnification	14
	 	 	 
	ARTICLE V     Conditions to Close	 
	 	 	 
	Section 5.01.	Conditions to Obligations of H/Cell	14
	 	 	 
	Section 5.02.	Conditions to Obligations of the Pride Shareholders	15
	 	 	 
	ARTICLE VI     Termination	 
	 	 	 
	Section 6.01.	Termination Events	15
	 	 	 
	Section 6.02.	Effect of Termination	16
	 	 	 
	ARTICLE VII     General Provisions	 
	 	 	 
	Section 7.01.	Statutes	16
	 	 	 
	Section 7.02.	Non-Business Days	16
	 	 	 
	Section 7.03.	Amendments; Waivers	16
	 	 	 
	Section 7.04.	Assignment	17
	 	 	 
	Section 7.05.	No Third-Party Beneficiaries	17
	 	 	 
	Section 7.06.	Notices	17
	 	 	 
	Section 7.07.	Interpretation; Exhibits and Sections; Certain Definitions	18
	 	 	 
	Section 7.08.	Counterparts	23
	 	 	 
	Section 7.09.	Entire Agreement; Survival	23
	 	 	 
	Section 7.10.	Severability	24


 




    - ii -


     


    

 


Table
of Contents


(continued)


 


	 	 	Page
	 	 	 
	Section 7.11.	Governing Law	24
	 	 	 
	Section 7.12.	Waiver of Jury Trial	24
	 	 	 
	Section 7.13.	Consent to Jurisdiction	24
	 	 	 
	Section 7.14.	Separate Counsel	25


 




    - iii -


     


    

 


SHARE EXCHANGE
AGREEMENT


 


SHARE EXCHANGE AGREEMENT
(the “Agreement”), dated as of January 31, 2017, by and among H/Cell Energy Corporation, a Nevada corporation
(“H/Cell”), The Pride Group (QLD) Pty Ltd, an Australian corporation (the “Pride”) and the
shareholders of Pride listed on the signature pages hereof (collectively, the “Pride Shareholders”). Capitalized
terms used but not otherwise defined herein shall have the meanings set forth in Section 7.07 hereof unless the context
clearly provides otherwise.


 


WHEREAS, the Pride Shareholders
own an aggregate of 97,939 shares of Class A Ordinary Shares (the “Shares”), of Pride, which Shares constitute
all of the issued and outstanding shares of capital stock of Pride;


 


WHEREAS, subject to the
terms and conditions set forth herein, H/Cell desires to acquire from the Pride Shareholders all of the Shares and the Pride Shareholders
desire to transfer to H/Cell all of the Shares in exchange for shares of common stock of H/Cell;


 


WHEREAS, upon consummation
of the transactions contemplated by this Agreement, Pride will become a 100% wholly-owned subsidiary of H/Cell; and


 


WHEREAS,
it is intended that the terms and conditions of this Agreement comply in all respects with Section 368(a)(1)(B) and/or
Section 351 of the Code and the regulations corresponding thereto, so that the Acquisition shall qualify as a tax free reorganization
under the Code, and that this share exchange transaction shall qualify as a transaction in securities exempt from registration
or qualification under the Securities Act of 1933, as amended and in effect on the date of this Agreement.


 


NOW, THEREFORE, in consideration
of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the Parties hereby agree as follows:


 


ARTICLE
I


 


EXCHANGE OF SHARES;
CLOSING


 


Section
1.01. Exchange of Shares; NTAV Adjustment.


 


(a)          On
the terms and subject to the conditions of this Agreement, at the Closing, the Pride Shareholders shall sell, convey, assign, transfer
and deliver to H/Cell certificates representing the Shares held by each Pride Shareholder as set forth in Column II of Annex
I hereto, which in the aggregate shall constitute 100% of the issued and outstanding equity securities of Pride, in exchange
for an aggregate of 3,800,000 newly and duly issued, fully paid and non-assessable shares of H/Cell’s common stock, $0.0001
par value per share (the “Acquisition Shares”). For all purposes of this Agreement, the Acquisition Shares shall
be valued at $0.50 per share, for a total acquisition value of the Shares of One Million Nine Hundred Thousand Dollars ($1,900,000),
subject to adjustment as set forth herein. At the Closing, the outstanding Shares beneficially owned by the Pride Shareholders
shall be contributed and transferred to H/Cell and H/Cell shall issue the number of shares of Acquisition Shares set forth opposite
such party’s name in Column III on Annex I attached hereto. 90% of the Acquisition Shares, as set forth opposite such
party’s name in Column IV on Annex I attached hereto, shall be delivered within five (5) business days of the Closing
Date.


 




     


     


    

 


(b)          Within
ninety (90) days after the Closing Date, H/Cell shall cause to be prepared and delivered to the Pride Shareholders a calculation
of Pride’s net tangible asset value as of the Closing Date. Net tangible asset value is defined as total assets minus total
liabilities minus intangible assets (“NTAV”). The Pride Shareholders shall have a period of sixty (60) days
to review the NTAV calculation. In the event the Pride Shareholders and H/Cell are unable to agree upon the NTAV after good faith
negotiations for a period of 20 days, the Pride Shareholders and H/Cell shall submit such dispute for resolution to Rosenberg Rich
Baker Berman & Company (the “Independent Accounting Firm”), which shall determine and report to the parties
and such report shall be final, binding and conclusive on the parties hereto. If the Independent Accounting Firm determines that
the NTAV is within five percent (5%), whether greater or less, below the NTAV determined by H/Cell, then the parties shall equally
share the cost of the Independent Accounting Firm. If the Independent Accounting Firm determines that the NTAV is more than five
percent (5%) above the NTAV determined by H/Cell, then the Pride Shareholders shall pay the fees and expenses of the Independent
Accounting Firm. If the Independent Accounting Firm determines that the NTAV is more than five percent (5%) below the NTAV determined
by H/Cell, then H/Cell shall pay the fees and expenses of the Independent Accounting Firm. The parties shall cooperate with one
another and provide reasonable access of all pertinent books and records to the other party. In the event the NTAV as of the Closing
Date shall be less than AUD $200,000, the Pride Shareholders shall be required to pay H/Cell the amount of the shortfall through
the return to H/Cell of such number of Acquisition Shares equal to the shortfall divided by $0.50. In the event the NTAV as of
the Closing Date shall be greater than AUD $300,000, H/Cell shall be required to pay the Pride Shareholders the amount of such
excess through the issuance to the Pride Shareholders of such number of additional Acquisition Shares equal to the excess divided
by $0.50. Any Acquisition Shares required to be issued or returned pursuant to this Section 1.01(b) shall be completed within ten
(10) days after determination of the NTAV.


 


(c)          In
order to satisfy any amounts which the Pride Shareholders may be required to deliver to H/Cell as a result of a deficiency in the
NTAV, 10% of the Acquisition Shares (the “Escrowed Shares”), as set forth opposite such party’s name in
Column V on Annex I attached hereto, shall be deposited into an escrow account until the NTAV as of the Closing Date shall
be determined and any deficiency in the NTAV shall be settled by the return to H/Cell of such number of Escrowed Shares equal to
the shortfall divided by $0.50. The Escrowed Shares shall be held for the benefit of the Pride Shareholders in accordance with
their pro rata ownership of the Shares as set forth on Schedule 1.1. The Escrowed Shares shall be held in accordance with
the terms and conditions set forth in the escrow agreement attached hereto as Exhibit 1.01 (the “Escrow Agreement”).


 


(d)          The
exchange of the Shares for the Acquisition Shares is referred to in this Agreement as the “Acquisition.”


 




    	 	- 2 -	 



     


    

 


Section
1.02. Closing Date. The closing of the Acquisition and the other transactions contemplated hereby (the “Closing”)
shall take place at the offices of Sichenzia Ross Ference Kesner LLP, 61 Broadway, 32nd Floor, New York, New York 10006,
at 10:00 a.m. on January 31, 2017 or on such other date as mutually agreed to by the parties (the “Closing Date”).
The Closing shall be deemed to be effective as of 12:01 a.m. on the Closing Date.


 


Section
1.03. Transactions to be Effected at the Closing. At the Closing:


 


(a)          the
Pride Shareholders shall deliver to H/Cell:


 


(i)          certificates
representing the Shares, duly endorsed in blank or accompanied by stock powers duly endorsed in blank in proper form for transfer;
and


 


(ii)         the
Escrow Agreement, executed by the Pride Shareholders.


 


(b)          H/Cell
shall deliver to the Pride Shareholders:


 


(i)          Certificates
representing the Acquisition Shares, minus the Escrowed Shares (which, the Pride Shareholders agree, may be delivered within five
(5) days after the Closing Date); and


 


(ii)         the
Escrow Agreement, executed by H/Cell and the escrow agent.


 


ARTICLE
II


 


Representations
and Warranties OF The Pride Shareholders


 


For purposes of this
Agreement, any statement made to the knowledge of Pride shall mean the knowledge of the Pride Shareholders. A Pride Shareholder
shall be deemed to have “knowledge” of a particular fact or other matter if such Pride Shareholder is actually aware
of such fact or other matter, or should, by reason of his or her position as an owner, director or executive officer of Pride,
reasonably be expected to be aware of such fact or other matter.


 


Except as set forth in
the disclosure letter, dated the date of this Agreement and delivered by the Pride Shareholders to H/Cell prior to the execution
of this Agreement, together with any supplements delivered by the Pride Shareholders to H/Cell at or prior to the Closing Date
to reflect any necessary changes between the date of execution of this Agreement and the Closing Date (the “Pride
Disclosure Letter”), which Pride Disclosure Letter identifies the section (or, if applicable, subsection) to which
such exception relates (it being understood that disclosure in one section shall also apply to other sections to the extent it
is reasonably apparent from the face of the disclosure that such disclosure would also apply to such other sections), the Pride
Shareholders hereby jointly and severally represent and warrant to H/Cell as of the date hereof as follows:


 




    	 	- 3 -	 



     


    

 


Section
2.01. Organization.


 


(a)          Except
as would not, individually or in the aggregate, reasonably be expected to have a Pride Material Adverse Effect, each of the Pride
Shareholders and Pride (i) has been duly organized and is validly existing in good standing (to the extent such concept is applicable)
under the Laws of its jurisdiction of organization, with all requisite corporate power and authority to own its properties and
conduct its business as currently conducted and (ii) is duly qualified as a foreign corporation for the transaction of business,
and is in good standing (to the extent such concept is applicable) under the Laws of each other jurisdiction in which it owns or
leases properties, or conducts any business so as to require such qualification.


 


(b)          Neither
the Pride Shareholders nor Pride is in breach or violation of any of its certificate of incorporation, bylaws or other Organizational
Documents, except for any breach or violation that would not, individually or in the aggregate, reasonably be expected to have
a Pride Material Adverse Effect. Prior to the Closing Date, the Pride Shareholders will deliver or make available to H/Cell true
and complete copies of Pride’s certificate of incorporation, bylaws or other Organizational Documents, each as amended to
date.


 


Section
2.02. Capitalization. The Shares are all of the issued and outstanding equity interests in Pride. All of the Shares
have been duly authorized and validly issued, are fully paid and nonassessable and free of preemptive rights, with no personal
liability attaching to the ownership thereof, and are owned of record and beneficially by the Pride Shareholders. All of the Shares
were issued in compliance with applicable Laws. None of the Shares were issued in violation of any agreement, arrangement or commitment
to which the Pride Shareholders or Pride is a party or is subject to or in violation of any preemptive or similar rights of any
Person. There are no outstanding or authorized options, warrants or other rights of any kind relating to the sale, issuance or
voting of any Shares or any securities convertible into or evidencing the right to purchase any Shares. Pride does not own any
shares of capital stock of or equity interests in (including any securities exercisable or exchangeable for or convertible into
capital stock of or other voting or equity interests in) any other Person.


 


Section
2.03. Authority; Execution and Delivery; Enforceability. Each Pride Shareholder has full power and authority to execute
this Agreement and to consummate the Acquisition and the other transactions contemplated hereby. The execution and delivery by
the Pride Shareholders of this Agreement and the consummation by the Pride Shareholders of the Acquisition and the other transactions
contemplated hereby have been duly authorized by all necessary corporate action. The Pride Shareholders have duly executed and
delivered this Agreement and, assuming that this Agreement is the valid and binding agreement of H/Cell, this Agreement constitutes
a legal, valid and binding obligation of the Pride Shareholders, enforceable against each Pride Shareholder in accordance with
its terms, subject to bankruptcy, insolvency, reorganization and other Laws affecting creditors’ rights generally, and to
general principles of equity.


 




    	 	- 4 -	 



     


    

 


Section
2.04. Title to Shares. Each Pride Shareholder owns, beneficially and of record, good and marketable title to the
number of Shares set forth opposite such Pride Shareholder’s name in Column II of Annex I hereto, free and clear of
all security interests, liens, adverse claims, encumbrances, equities, proxies, options or voting agreements. The Pride Shareholders
represent that they each have no right or claims whatsoever to any equity interests of Pride, other than the Shares and do not
have any options, warrants or any other instruments entitling any of them to exercise or purchase or convert into additional equity
interests of Pride. At the Closing, the Pride Shareholders shall convey to H/Cell good and marketable title to the Shares, free
and clear of any security interests, liens, adverse claims, encumbrances, equities, proxies, options, shareholders’ agreements
or restrictions.


 


Section
2.05. Acquisition Shares for Investment Purposes. The Pride Shareholders each acknowledge that the Acquisition Shares
will not be registered pursuant to the Securities Act or any applicable state securities laws, that the Acquisition Shares will
be characterized as “restricted securities” under federal securities laws, and that under such laws and applicable
regulations the Acquisition Shares cannot be sold or otherwise disposed of without registration under the Securities Act or an
exemption therefrom. In this regard, each Pride Shareholder is familiar with Rule 144 promulgated under the Securities Act, as
currently in effect, and understands the resale limitations imposed thereby and by the Securities Act. Further, each Pride Shareholder
acknowledges and agrees that:


 


(a)          Each
Pride Shareholder is acquiring the Acquisition Shares for investment, for such Pride Shareholder’s own account and not as
a nominee or agent, and not with a view to the resale or distribution of any part thereof, and each Pride Shareholder has no present
intention of selling, granting any participation in, or otherwise distributing the same.  Each Pride Shareholder further
represents that he, she or it does not have any contract, undertaking, agreement or arrangement with any Person to sell, transfer
or grant participation to such person or to any third person, with respect to any of the Acquisition Shares.


 


(b)          Each
Pride Shareholder understands that the Acquisition Shares are not registered under the Securities Act on the ground that the sale
and the issuance of securities hereunder is exempt from registration under the Securities Act pursuant to Section 4(a)(2) thereof,
and that H/Cell’s reliance on such exemption is predicated on each Pride Shareholder’s representations set forth herein.


 


(c)          The
Pride Shareholders acknowledges that the certificates representing the Acquisition Shares shall each conspicuously set forth on
the face or back thereof a legend in substantially the following form:


 


“THESE SECURITIES HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN
THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THE SECURITIES UNDER SAID ACT OR PURSUANT TO AN EXEMPTION FROM REGISTRATION
OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.”


 




    	 	- 5 -	 



     


    

 


Section
2.06. Accredited Investor Status. Each of the Pride Shareholders is an “Accredited Investor” as that
term is defined in Rule 501 of Regulation D promulgated under the Securities Act.


 


Section
2.07.No Conflicts; Consents.


 


(a)          Except
as set forth in Section 2.07(a) of the Pride Disclosure Letter, the execution and delivery by the Pride Shareholders of
this Agreement do not, and the performance of this Agreement, including the consummation of the Acquisition and the other transactions
contemplated hereby and compliance by the Pride Shareholders with the terms hereof will not, (1) conflict with, constitute or result
in any violation or breach of or default (with or without notice or lapse of time, or both) under, or give rise to a right of termination,
cancellation or acceleration of any obligation or to loss of a material benefit under, or result in the creation of any Lien (other
than Permitted Liens) upon any of the properties or assets of Pride under, any provision of (i) the certificate of incorporation,
bylaws or other Organizational Documents of the Pride Shareholders or Pride, (ii) any Material Contract to which Pride is a party
or by which any of its properties or assets is bound, or (iii) any Law applicable to Pride or its properties or assets, other than
in each case any such items that, individually or in the aggregate, have not had and would not reasonably be expected to have a
Pride Material Adverse Effect, or (2) result in the creation or imposition of any Lien other than Permitted Liens on any properties
or assets of Pride.


 


(b)          Except
as set forth on Section 2.07(b) of the Pride Disclosure Letter, no notice to, or Consent of, any Person, or registration,
declaration or filing with, any Governmental Entity is required to be obtained or made by the Pride Shareholders or Pride in connection
with the Pride Shareholders’ execution, delivery and performance of this Agreement or the Pride Shareholders’ consummation
of the Acquisition or the other transactions contemplated hereby except for such Consents, registrations, declarations or filings
which, individually or in the aggregate, have not had and would not reasonably be expected to have a Pride Material Adverse Effect.


 


Section
2.08. Financial Statements. The Pride Shareholders have delivered, or will deliver prior to Closing, to H/Cell copies
of the following financial statements (which include all notes and schedules attached thereto), all of which are true, complete
and correct, have been prepared from the books and records of Pride in accordance with generally accepted accounting principles
(“GAAP”) consistently applied with past practice and fairly present the financial condition, assets, liabilities
and results of operations of Pride as of the dates thereof and for the periods covered thereby:


 


the reviewed
balance sheet of Pride at December 31, 2015 and 2014, and the related statements of operations, and of cash flows of Pride for
the periods then ended and (ii) the unaudited balance sheet of Pride as of September 30, 2016 and the related compiled statement
of operations of Pride for the nine months ended September 30, 2016 and 2015 (such statements, including the related notes and
schedules thereto, are referred to herein as the “Financial Statements.”)


 




    	 	- 6 -	 



     


    

 


In such Financial
Statements, the statements of operations do not contain any material items of special or nonrecurring income or any other material
income not earned in the ordinary course of business Except as set forth on Section 2.08 of the Pride Disclosure Letter,
and the financial statements for the interim periods indicated include all adjustments, which consist of only normal recurring
accruals, necessary for such fair presentation. There are no facts known to any of the Pride Shareholders or Pride that, under
GAAP consistently applied, would alter the information contained in the foregoing Financial Statements in any material way.


 


The final Balance Sheet
will be complete and correct in all material respects determined in accordance with GAAP as of the Balance Sheet Date. For the
purposes hereof, the balance sheet of Pride as of September 30, 2016 is referred to as the “Balance Sheet” and
September 30, 2016 is referred to as the “Balance Sheet Date”.


 


Section
2.09. Absence of Changes. Since the Balance Sheet Date until the date hereof, no event or circumstance has occurred
that, individually, or in the aggregate, has had or would reasonably be expected to have a Pride Material Adverse Effect.


 


Section
2.10. No Undisclosed Liabilities. Except as and to the extent reflected or reserved against in Pride’s Financial
Statements or as set forth on Section 2.10 of the Pride Disclosure Letter, there are no liabilities or obligations of Pride
of any kind whatsoever exceeding $1,000, individually or in the aggregate, whether accrued, fixed, absolute, contingent, determined
or determinable, and including without limitation (i) liabilities to former, retired or active employees of Pride under any
pension, health and welfare benefit plan, vacation plan or other plan of Pride, (ii) tax liabilities incurred in respect of
or measured by income for any period prior to the close of business on the Balance Sheet Date, or arising out of transactions entered
into, or any state of facts existing, on or prior to said date, and (iii) contingent liabilities in the nature of an endorsement,
guarantee, indemnity or warranty, and there is no condition, situation or circumstance existing or which has existed that could
reasonably be expected to result in any liability of Pride which is of a nature that would be required to be disclosed on its Financial
Statements in accordance with GAAP, other than liabilities and contingent liabilities incurred in the ordinary course of business
since the Balance Sheet Date consistent with Pride’s recent customary business practice, none of which is materially adverse
to Pride.


 


Section
2.11. Litigation. There is no pending, or to the Pride Shareholders’ Knowledge, threatened in writing action,
claim, suit, proceeding or investigation against Pride, or to which any property, assets or rights of Pride is subject, nor is
Pride subject to any Order that remains outstanding or unsatisfied, in each case, except as would not, individually or in the aggregate,
reasonably be expected to have a Pride Material Adverse Effect.


 


Section
2.12. Condition of Assets. The buildings, plants, structures, furniture, fixtures, machinery, equipment, vehicles
and other items of tangible personal property of Pride are operational and in a condition adequate and sufficient for use in Pride’s
business as it has been conducted to date and as it shall be conducted in the future by H/Cell, ordinary wear and tear excepted.


 




    	 	- 7 -	 



     


    

 


Section
2.13. Compliance with Laws; Permits.


 


(a)          Pride
has all permits, licenses, franchises, authorizations, Orders and approvals of, and has made all filings, applications and registrations
with, all Governmental Entities that are required in order to permit it to own, lease or license their properties, assets and rights,
and to carry on their business as presently conducted, except where the failure to have such permits, licenses, franchises, authorizations,
Orders and approvals or the failure to make such filings, applications and registrations would not, individually or in the aggregate,
reasonably be expected to have a Pride Material Adverse Effect. All such permits, licenses, certificates of authority, Orders and
approvals are in full force and effect and, to the Pride Shareholders’ Knowledge, no suspension or cancellation of any of
them is threatened in writing, and all such filings, applications and registrations are current, except where such absence, suspension
or cancellation would not, individually or in the aggregate, reasonably be expected to have a Pride Material Adverse Effect.


 


(b)          Pride
is in compliance with all applicable Laws, except where the failure to so comply would not result in a Pride Material Adverse Effect.


 


Section
2.14. Tax Matters. Except as would not, individually or in the aggregate, reasonably be expected to have a Pride
Material Adverse Effect, (i) there has been filed by or on behalf of Pride all material Tax Returns required to be filed by the
applicable company, (ii) all Taxes of Pride (whether or not shown on such Tax Returns) have been or will be paid in a timely fashion
or, where payment is not yet due, have been adequately provided for in the financial statements of Pride in accordance with GAAP,
and (iii) no audit or other proceeding by any Governmental Entity is pending with respect to any Taxes due from Pride, except with
respect to matters for which adequate reserves have been established in accordance with GAAP. Notwithstanding the above, the Pride
Shareholders agree to fully indemnify H/Cell in any amount for any Tax payments H/Cell ultimately has to make with respect to any
time period prior to the Closing Date as a result of findings by a Governmental Entity that the Pride Shareholders or Pride have
violated applicable Law.


 


Section
2.15. Labor and Employee Benefit Matters.


 


(a)          Except
as would not, individually or in the aggregate, reasonably be expected to have a Pride Material Adverse Effect, (i) Pride is in
compliance in all material respects with all applicable Laws respecting employment and employment practices, terms and conditions
of employment and wages and hours, (ii) there is no unfair labor practice complaint against Pride pending before any Governmental
Entity, (iii) there is no labor strike, dispute, slowdown or stoppage actually pending or, to the Knowledge of the Pride Shareholders,
threatened against Pride, (iv) there are no unpaid dues, assessments, fines or other expenses regarding Pride relating to any union
violation, audit and/or issue, and (v) except as set forth on Section 2.15(a) of the Pride Disclosure Letter, there are
no collective bargaining or other labor union Contracts to which Pride is a party or by which Pride is bound.


 




    	 	- 8 -	 



     


    

 


(b)          Section
2.15(b) of the Pride Disclosure Letter sets forth a list as of the date of this Agreement of each material Employee Program
sponsored, maintained, or contributed to by Pride in which present or former employees of Pride participate or for which Pride
has any material liability (collectively, the “Benefit Plans”). Except as set forth in Section 2.15(b)
of the Pride Disclosure Letter, no Benefit Plan is a (pension or non-pension) employee benefit plan to which more than one employer
contributes and which is maintained pursuant to one or more collective bargaining agreements.


 


(c)          Except
as would not, individually or in the aggregate, reasonably be expected to have a Pride Material Adverse Effect, the Benefit Plans
are in compliance with all applicable requirements of applicable Laws and have been administered in accordance with their terms
and such Laws.


 


(d)          There
are no pending or, to the Knowledge of the Pride Shareholders, threatened, claims with respect to any Benefit Plans, other than
ordinary and usual claims for benefits by participants and beneficiaries, that would, individually or in the aggregate, reasonably
be expected to have a Pride Material Adverse Effect.


 


Section
2.16. Real Property. Pride does not own any real property. Section 2.16 of the Pride Disclosure Letter sets
forth a complete and correct list in all material respects of the real property leased by Pride (the “Leased Real Property,”
and the leases, together with any amendments and modifications thereto, pursuant to which such real property is leased, the “Leases”),
which list sets forth each Lease and the address, landlord and tenant for each Lease. Pride is not a lessor, sublessor or grantor
under any lease, sublease or other instrument granting to any other Person any right to the possession, lease, occupancy or enjoyment
of any Leased Real Property. To the Pride Shareholders’ Knowledge, Pride has valid leasehold interest in all of the Leased
Real Property, subject to no Liens other than Permitted Liens. Pride is in compliance with the terms of all leases relating to
the Leased Real Property to which it is a party, except such compliance which has not had or would not reasonable be expect to
have, individually or in the aggregate, a Pride Material Adverse Effect. To the Pride Shareholders’ Knowledge, all such material
Leases relating to the Leased Real Property are in full force and effect, and Pride enjoys peaceful and undisturbed possession
under all such applicable leases.


 


Section
2.17. Environmental.


 


(a)          Pride
is in compliance with all applicable Environmental Laws and has obtained and is in compliance with all applicable permits, licenses
and authorizations required under applicable Environmental Laws, except, in each case, as would not, individually or in the aggregate,
reasonably be expected to have a Pride Material Adverse Effect.


 


(b)          Pride
has not received a notice in writing of violation or notification in writing of liability or potential liability arising out of
any Environmental Law, and there is no Litigation or claim pending or, to the Pride Shareholders’ Knowledge, overtly threatened
in writing under any Environmental Law, except in each case, with respect to any violation or liability that would not, individually
or in the aggregate, reasonably be expected to have a Pride Material Adverse Effect.


 


(c)          Except
for matters that would not, individually or in the aggregate, reasonably be expected to have a Pride Material Adverse Effect, no
Release of Hazardous Substances has occurred at, on, above, under or from any real property currently or formerly owned, leased,
operated or used by Pride that has resulted or would reasonably be expected to result in a material investigation or remedial action.


 




    	 	- 9 -	 



     


    

 


 


Section
2.18. Contracts. Each written contract to which Pride is a party or by which it is bound, which is material to the
business of such company (each a “Material Contract”), is valid and binding on Pride in accordance with its
terms and is in full force and effect, except to the extent that the invalidity or non-binding nature of any Material Contract
would not, individually or in the aggregate, reasonably be expected to have a Pride Material Adverse Effect, and none of Pride
or, to the Pride Shareholders’ Knowledge, any other party thereto is in breach or of default under (or received any written
notice alleging to be in breach of or default under) of any such Material Contract, or has provided or received any written notice
of any intention to terminate, any Material Contract, except for defaults which would not, individually or in the aggregate, reasonably
be expected to have a Pride Material Adverse Effect.


 


Section
2.19. Intellectual Property.


 


(a)          Except
as would not, individually or in the aggregate, reasonably be expected to have a Pride Material Adverse Effect, Pride owns, or
possess sufficient and legally enforceable licenses or other rights to use, any and all Intellectual Property necessary for the
conduct of the businesses and operations of Pride as currently conducted.


 


(b)          To
the Pride Shareholders’ Knowledge, the conduct of the business of Pride does not infringe, conflict with or otherwise violate
any Intellectual Property of any Person, and Pride has not received written notice or has knowledge of any such infringement, conflict
or other violation, except as would not, individually or in the aggregate, reasonably be expected to have a Pride Material Adverse
Effect.


 


Section
2.20. Brokers and Finders. Neither Pride nor its Affiliates have retained any agent, broker, investment banker, financial
advisor or other firm or Person that is or will be entitled to any brokers’ or finder’s fee or any other commission
or similar fee in connection with any of the transactions contemplated by this Agreement.


 


Section
2.21. Disclosure. No representation or warranty of the Pride Shareholders or Pride in this Agreement and no statement
in the Pride Disclosure Letter contains any material untrue statement or omits to state a material fact necessary to make the statements
herein or therein, in light of the circumstances in which they were made, not misleading. No notice given pursuant to Section
7.06 will contain any untrue statement or omit to state a material fact necessary to make the statements therein or in this
Agreement, in light of the circumstances in which they were made, not misleading. To the Pride Shareholders’ Knowledge, there
is no fact that has specific application to Pride (other than general economic or industry conditions) that could have a Pride
Material Adverse Effect on the financial or other condition, results of operations, assets, liabilities, equity, business or prospects
of Pride that has not been set forth in this Agreement.


 


Section
2.22. Disclaimer of Other Representations and Warranties. Except as otherwise expressly set forth in this Article II,
the Pride Shareholders make no other representations or warranties and expressly disclaims any other representations or warranties
of any kind or nature, express or implied, as to the condition, value or quality of the business of Pride or the assets of Pride,
and the Pride Shareholders specifically disclaims any implied representation or warranty of merchantability, usage, suitability
or fitness for any particular purpose with respect to the assets of Pride, or any part thereof.


 




    	 	- 10 -	 



     


    

 


ARTICLE
III


 


Representations
and Warranties of H/Cell


 


H/Cell hereby represents
and warrants to the Pride Shareholders as follows as of the date hereof:


 


Section
3.01. Organization.


 


(a)          H/Cell
has been duly incorporated and is validly existing as a corporation in good standing under the Laws of the State of Nevada , with
all requisite corporate power and authority to own its properties and conduct its business as currently conducted, and, except
as would not, individually or in the aggregate, reasonably be expected to have an H/Cell Material Adverse Effect, is duly qualified
as a foreign limited liability company for the transaction of business, and is in good standing (to the extent such concept is
applicable) under the Laws of each other jurisdiction in which it owns or leases properties, or conducts any business so as to
require such qualification.


 


(b)          H/Cell
is not in breach or violation of its articles of incorporation, bylaws, or other Organizational Documents.


 


Section
3.02. Authority; Execution and Delivery; Enforceability. H/Cell has full power and authority to execute this Agreement
and to consummate the Acquisition and the other transactions contemplated hereby. The execution and delivery by H/Cell of this
Agreement and the consummation by H/Cell of the Acquisition and the other transactions contemplated hereby have been duly authorized
by all necessary corporate action. H/Cell has duly executed and delivered this Agreement and, assuming that this Agreement is the
valid and binding agreement of the Pride Shareholders, this Agreement constitutes a legal, valid and binding obligation of H/Cell,
enforceable against H/Cell in accordance with its terms, subject to bankruptcy, insolvency, reorganization and other Laws affecting
creditors’ rights generally, and to general principles of equity.


 


Section
3.03. No Conflicts; Consents.


 


(a)          The
execution and delivery by H/Cell of this Agreement do not, and the consummation of the Acquisition and the other transactions contemplated
hereby and compliance by H/Cell with the terms hereof will not, (i) have an H/Cell Material Adverse Effect or (ii) conflict with,
constitute or result in any violation or breach of or default (with or without notice or lapse of time, or both) under, or give
rise to a right of termination, cancellation or acceleration of any obligation or to loss of a material benefit under, or result
in the creation of any Lien upon any of the properties or assets of H/Cell under, any provision of (A) its articles of incorporation,
bylaws, other governing instrument or comparable Organizational Documents of H/Cell, (B) any contract to which H/Cell is a party
or by which any of its properties or assets is bound, (C) any Law applicable to H/Cell or its properties or assets, other than,
in the case of clauses (B) and (C) above, any such items that, individually or in the aggregate, have not had and would not reasonably
be expected to have an H/Cell Material Adverse Effect.


 




    	 	- 11 -	 



     


    

 


(b)          No
Consent of, or registration, declaration or filing with, any Governmental Entity is required to be obtained or made by H/Cell in
connection with the execution, delivery and performance of this Agreement or the consummation of the Acquisition or the other transactions
contemplated hereby.


 


Section
3.04. Investment Representation. H/Cell is acquiring the Shares for its own account, for investment purposes only
and not with a view to the distribution (as such term is used in Section 2(11) of the Securities Act of 1933, as amended (the "Securities
Act")) thereof. H/Cell understands that the Shares have not been registered under the Securities Act and cannot be sold
unless subsequently registered under the Securities Act or an exemption from such registration is available.


 


Section
3.05. Brokers and Finders. Neither H/Cell nor its Affiliates has retained any agent, broker, investment banker, financial
advisor or other firm or Person that is or will be entitled to any brokers’ or finder’s fee or any other commission
or similar fee in connection with any of the transactions contemplated by this Agreement.


 


ARTICLE
IV


 


Covenants


 


Section
4.01. Access and Investigation. Between the date of this Agreement and the Closing Date and upon reasonable advance
notice from H/Cell, the Pride Shareholders will, and will cause Pride and its representatives to, (a) afford H/Cell and its representatives
and prospective lenders and their representatives full and free access to Pride’s personnel, properties (including subsurface
testing), Contracts, books and records, and other documents and data, (b) furnish such Persons with copies of all such Contracts,
books and records, and other documents and data as H/Cell may reasonably request, and (c) furnish such Persons with such additional
financial, operating and other data and information as H/Cell may reasonably request.


 


Section
4.02. Negative Covenant. Except as otherwise expressly permitted by this Agreement, between the date of this Agreement
and the Closing Date, the Pride Shareholders will not, and will not cause or permit Pride to, without the prior consent of H/Cell,
(a) make any modifications to any Material Contract or Permit except in the ordinary course of business and consistent with past
business practices, or (b) enter into any compromise or settlement of any pending or threatened Litigation.


 


Section
4.03. Required Approvals. As promptly as practicable after the date of this Agreement, (i) the Pride Shareholders
will, and will cause Pride to obtain such consents set forth on Section 2.07(b) of the Pride Disclosure Letter (each a “Material
Consent”), and (ii) H/Cell will obtain a fairness opinion that the number of Acquisition Shares being issued to the Pride
Shareholders in exchange for the Shares is fair (the “Fairness Opinion”). Between the date of this Agreement
and the Closing Date, the Pride Shareholders will, and will cause Pride to cooperate with H/Cell with respect to all filings that
H/Cell elects to make or that H/Cell is required by Law to make in connection with the Acquisition.


 




    	 	- 12 -	 



     


    

 


Section
4.04. Retention of Books and Records. For a period of seven (7) years following the Closing, H/Cell shall retain
the books and records of Pride, and upon reasonable notice, afford the officers, employees, agents and representatives of the Pride
Shareholders reasonable access (including the right to make photocopies, at the expense of the Pride Shareholders), during normal
business hours, to such books and records.


 


Section
4.05. Expenses; Transfer Taxes.


 


(a)          Except
as otherwise set forth in this Agreement, all costs and expenses incurred in connection with this Agreement and the transactions
contemplated hereby shall be paid by the Party incurring such expense, including all costs and expenses incurred pursuant to this
Section 4.05.


 


(b)          Notwithstanding
anything to the contrary contained herein, H/Cell shall pay the amount of any documentary, sales, use, real property transfer,
real property gains, registration, value-added, transfer, stamp, recording and other similar Taxes, fees, and costs together with
any interest thereon, penalties, fines, costs, fees, additions to tax or additional amounts with respect thereto incurred in connection
with this Agreement and the transactions contemplated hereby. Each Party shall use commercially reasonable efforts to avail itself
of any available exemptions from any Taxes, and to cooperate with the other Parties in providing any information and documentation
that may be necessary to obtain such exemptions.


 


Section
4.06. Post-Closing Cooperation. The Pride Shareholders and H/Cell shall cooperate with each other, and shall cause
their Affiliates and their officers, employees, agents, auditors and representatives to cooperate with each other, for a reasonable
period after the Closing to ensure the orderly transition of Pride from the Pride Shareholders to H/Cell and to minimize any disruption
to Pride and the other respective businesses of the Pride Shareholders and H/Cell that may result from the transactions contemplated
by this Agreement. After the Closing, upon reasonable written notice, the Pride Shareholders and H/Cell shall furnish or cause
to be furnished to each other and their Affiliates and their respective employees, counsel, auditors and representatives access,
during normal business hours, to such information and assistance relating to Pride (to the extent within the control of such Party)
as is reasonably necessary for financial reporting and accounting matters.


 


Section
4.07. Publicity. No public release or announcement concerning the Acquisition and the other transactions contemplated
by this Agreement shall be issued by any Party following the Closing Date without the prior consent of the other Parties (which
consent shall not be unreasonably withheld), except as such release or announcement may be required by Law or the rules or regulations
of any securities exchange, in which case the Party required to make the release or announcement shall allow the other Party reasonable
time to comment on such release or announcement in advance of such issuance.


 




    	 	- 13 -	 



     


    

 


Section
4.08. Further Assurances. From time to time, as and when requested by any Party, each Party shall execute and deliver,
or cause to be executed and delivered, all such documents and instruments and shall take, or cause to be taken, all such further
or other actions, as such other Party may reasonably deem necessary or desirable to complete the Acquisition and to consummate
the transactions contemplated by this Agreement.


 


Section
4.09. Survival and Right to Indemnification.


 


(a)          All
of the Pride Shareholders’ representations, warranties, covenants, and/or obligations in this Agreement, and any other certificate
or document delivered pursuant to this Agreement will survive the Closing and the consummation of the transactions contemplated
herein for a one year period from the Closing; however, that representations and warranties with respect to tax and securities
law matters shall survive for the applicable statute of limitations.


 


(b)          The
Pride Shareholders will jointly and severally indemnify and hold harmless H/Cell and its employees, officers, directors and shareholders
(collectively, the “H/Cell Indemnified Persons”) and will pay to H/Cell Indemnified Persons the amount of any
damages arising, directly or indirectly, from any breach in any respect of any representation, warranty, covenant and /or obligation
made by the Pride Shareholders in this Agreement or in any other certificate or document delivered pursuant to this Agreement;
provided, however, that in no event shall the Pride Shareholders’ liability under this Agreement or in connection
with any certificate or document delivered pursuant to this Agreement exceed the value of the number of Acquisition Shares issued,
as adjusted.


 


ARTICLE
V


 


CONDITIONS TO CLOSE 


 


Section
5.01. Conditions to Obligations of H/Cell. The obligations of H/Cell to consummate the transactions contemplated
by this Agreement shall be subject to the fulfillment or H/Cell’s waiver, at or prior to the Closing, of each of the following
conditions:


 


(a)          All
of the Pride Shareholders’ and Pride’s representations and warranties in this Agreement (considered both collectively
and individually) must have been accurate in all material respects as of the date of this Agreement, and must be accurate in all
material respects as of the Closing Date as if then made;


 


(b)          All
of the covenants and obligations that the Pride Shareholders are required to perform or to comply with under this Agreement on
or before the Closing Date (considered both collectively and individually) must have been duly performed and complied with in all
material respects at H/Cell’s reasonable satisfaction;


 


(c)          Since
the date of this Agreement, no event or circumstance shall have occurred that, individually, or in the aggregate, has had or would
reasonably be expected to have a Pride Material Adverse Effect;


 


(d)          There
must not have been made or threatened by any Person who is not a party to this Agreement any claim asserting that such Person (a)
is the holder or the beneficial owner of, or has the right to acquire or to obtain beneficial ownership of, any stock of or any
other voting, equity or ownership interest in Pride, or (b) is entitled to all or any portion of the Acquisition Shares;


 




    	 	- 14 -	 



     


    

 


(e)          The
Fairness Opinion has been obtained; and


 


(f)          There
must not be in effect any Law or Order that (a) prohibits the Acquisition or consummation of the transactions contemplated under
this Agreement and (b) has been adopted or issued, or has otherwise become effective, since the date of this Agreement.


 


Section
5.02. Conditions to Obligations of the Pride Shareholders. The obligations of the Pride Shareholders to consummate
the transactions contemplated by this Agreement shall be subject to the fulfillment or the Pride Shareholders’ waiver, at
or prior to the Closing, of each of the following conditions:


 


(a)          All
of H/Cell’s representations and warranties in this Agreement (considered both collectively and individually) must have been
accurate in all material respects as of the date of this Agreement and must be accurate in all material respects as of the Closing
Date as if then made;


 


(b)          
All of the covenants and obligations that H/Cell is required to perform or to comply with under this Agreement on or before the
Closing Date (considered both collectively and individually) must have been duly performed and complied with in all material respects
at the Pride Shareholders’ reasonable satisfaction; and


 


(c)          There
must not be in effect any Law or Order that (a) prohibits the Acquisition or consummation of the transactions contemplated under
this Agreement and (b) has been adopted or issued, or has otherwise become effective, since the date of this Agreement.


 


ARTICLE
VI 


 


TERMINATION


 


Section
6.01. Termination Events. Subject to Section 6.02, this Agreement may, by notice given before or at the Closing,
be terminated:


 


(a)          by
mutual consent of H/Cell and the Pride Shareholders;


 


(b)          by
H/Cell or the Pride Shareholders if the Fairness Opinion is not obtained;


 


(c)          by
H/Cell if the Pride Shareholders have committed a material breach of any provision of this Agreement, H/Cell has not waived such
material breach and the Pride Shareholders have not cure such material breach within 30 days of receipt of written notice (with
specificity) of such;


 


(d)          by
the Pride Shareholders if H/Cell has committed a material breach of any provision of this Agreement, the Pride Shareholders have
not waived such material breach and H/Cell has not cure such material breach within 30 days of receipt of written notice (with
specificity) of such;


 




    	 	- 15 -	 



     


    

 


(e)          by
H/Cell if the satisfaction of any condition in Section 5.01 is or becomes impossible (other than through the failure of
H/Cell to comply with its obligations under this Agreement) and H/Cell has not waived such condition; or


 


(f)          by
the Pride Shareholders if the satisfaction of any condition in Section 5.02 is or becomes impossible (other than through
the failure of the Pride Shareholders to comply with their obligations under this Agreement) and the Pride Shareholders have not
waived such condition.


 


Section
6.02. Effect of Termination. Each Party’s right of termination under Section 6.01 is in addition to any other
rights it may have under this Agreement or otherwise, and the exercise of such right of termination will not be an election of
remedies. If this Agreement is terminated pursuant to Section 6.01, all obligations of the Parties under this Agreement will terminate,
except that the obligations in Sections 7.09, 7.10, 7.11, 7.12, and 7.13 will survive; provided, however, that if this Agreement
is terminated by a Party because of the breach of the Agreement by another Party or because one or more of the conditions to the
terminating Party’s obligations under this Agreement is not satisfied as a result of any other Party’s failure to comply
with its obligations under this Agreement, the terminating Party’s right to pursue all legal remedies, including the right
to an immediate refund of any amounts paid to the other Party under this Agreement, will survive such termination unimpaired.


 


ARTICLE
VII 


 


General
Provisions


 


Section
7.01. Statutes. Except as otherwise provided in this Agreement, any reference in this Agreement to a statute refers
to such statute and all rules and regulations made under it, as it or they may have been amended or re-enacted.


 


Section
7.02. Non-Business Days. Whenever payments are to be made or an action is to be taken on a day which is not a Business
Day, such payment shall be made or such action shall be taken on or not later than the next succeeding Business Day.


 


Section
7.03. Amendments; Waivers. This Agreement may only be amended, supplemented or otherwise modified by written agreement
signed by the Pride Shareholders and H/Cell. By an instrument in writing, H/Cell or the Pride Shareholders may waive compliance
by the other with any term or provision of this Agreement that such other Party was or is obligated to comply with or perform.
No waiver by a party of any default, misrepresentation or breach of warranty or covenant hereunder, whether intentional or not,
shall be deemed to extend to any prior or subsequent default, misrepresentation or breach of warranty or covenant hereunder or
affect in any way any rights arising by virtue of any prior or subsequent occurrence. No failure or delay by a party in exercising
any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude
any other or further exercise thereof or the exercise of any other right, power or privilege.


 




    	 	- 16 -	 



     


    

 


Section
7.04. Assignment. This Agreement and the rights and obligations under this Agreement shall not be assignable or transferable
by any Party (including by operation of law in connection with a merger or consolidation of such Party) without the prior written
consent of the other Party, such consent not to be unreasonably withheld. Any attempted assignment in violation of this Section
7.04 shall be void.


 


Section
7.05. No Third-Party Beneficiaries. This Agreement is for the sole benefit of the parties hereto and their respective
successors and permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other Person or
entity any legal or equitable right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.


 


Section
7.06. Notices. All notices, requests, consents, claims, demands, waivers and other communications hereunder shall
be in writing and shall be deemed to have been given (a) when delivered by hand (with written confirmation of receipt), (b) when
received by the addressee if sent by a nationally recognized overnight courier (receipt requested), (c) on the date sent by facsimile
(with confirmation of transmission) if sent during normal business hours of the recipient, and on the next Business Day if sent
after normal business hours of the recipient, or (d) on the third (3rd) Business Day after the date mailed, by certified or registered
mail, return receipt requested, postage prepaid. Such communications must be sent to the respective parties at the following addresses
(or at such other address for a party as shall be specified in a notice given in accordance with this Section 7.06):


 


	If to H/Cell, to:	 	H/Cell Energy Corporation

97 River Road

Flemington, NJ 08822

Phone: (908) 837-9097

Attention: Andrew Hidalgo, CEO
	 	 	 
	with a copy (which will not constitute notice) to:	 	Sichenzia Ross Ference Kesner LLP

61 Broadway, 32nd Floor

New York, New York 10006

Facsimile: (212) 930-9725

Attention:  James M. Turner, Esq.
	 	 	 
	If to the Pride Shareholders, to:	 	1/40 Wilson Avenue

Woombye QLD 4559 Australia

Attention:  Stephen Mullane


 


or to such other Persons, addresses or
facsimile numbers as may be designated in writing by the Person entitled to receive such communication as provided above.


 




    	 	- 17 -	 



     


    

 


Section
7.07. Interpretation; Exhibits and Sections; Certain Definitions.


 


(a)          The
table of contents and headings herein are for convenience of reference only, do not constitute part of this Agreement and shall
not be deemed to limit or otherwise affect any of the provisions hereof. Where a reference in this Agreement is made to a Section
or Exhibit, such reference shall be to a Section of or Exhibit to this Agreement unless otherwise indicated. Whenever the words
“include,” “includes” or “including” are used in this Agreement, they shall be deemed to be
followed by the words “without limitation.” A reference in this Agreement to $ or dollars is to U.S. dollars, except
any reference to AUD $ refers to Australian dollars. The words “hereof”, “herein” and “hereunder”
and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision
of this Agreement. References to “this Agreement” shall include all Exhibits hereto and the Pride Disclosure Letter.


 


(b)          The
parties have participated jointly in negotiating and drafting this Agreement. In the event that an ambiguity or a question of intent
or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden
of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement.


 


(c)          For
all purposes of this Agreement:


 


“Affiliate” means,
with respect to any Person, any other Person that directly or indirectly controls, is controlled by or is under common control
with, such Person. For the purposes of this definition, “control” (including, the terms “controlling,”
“controlled by” and “under common control with”), as applied to any Person, means the possession, directly
or indirectly, of the power to direct or cause the direction of the management and policies of that Person, whether through the
ownership of voting securities, by Contract or otherwise.


 


“Business
Day” means any day, other than Saturday, Sunday or any day on which banking institutions located in New York
City are authorized or required by Law or other governmental action to close.


 


“Code”
means the Internal Revenue Code of 1986, as amended.


 


“Pride Material
Adverse Effect” means any event, change, development, effect or occurrence (an “Effect”) that, individually
or together with any other Effect, is materially adverse to the business, assets, liabilities, results of operations or condition
(financial or otherwise) of Pride, taken as a whole; provided, however, that in determining whether a Pride Material Adverse Effect
has occurred, there shall be excluded any Effect to the extent resulting from the following: (a) any Effect affecting the businesses
or industries in which Pride operates (including general pricing changes), (b) any change in general economic or business conditions,
including changes in the financial, securities or credit markets (including changes in interest rates and currency rates), or changes
in such conditions in any area in which Pride operates, (c) any change in global or national political conditions, (d) the negotiation,
execution, announcement, pendency or performance of this Agreement and the transactions contemplated by this Agreement, (e) any
failure, in and of itself, of Pride to meet any estimates, expectations, forecasts or projections, including revenues, earnings
or other measures of financial performance, for any period; provided, however, that the facts and circumstances underlying any
such failure may, except as may be provided in subsections (a), (b), (c), (d), (f), (g), (h), (i) or (j) of this definition, be
considered in determining whether a Pride Material Adverse Effect has occurred, (f) any change in GAAP or other accounting standards
or any change in any Laws or interpretations thereof, in each case, after the date of this Agreement, (g) any act of God or any
change that is the result of any outbreak or escalation of acts of war, material armed hostilities or other material international
or national calamity, acts of terrorism or natural disasters, (h) any loss of or adverse change in the business relationship between
Pride, on the one hand, and H/Cell or any of its Affiliates, on the other hand, (i) any fees, expenses or change of control payments
incurred in connection with this Agreement and the transactions contemplated by this Agreement or (j) any action expressly required
or permitted by this Agreement, including actions required to be taken by this Agreement upon the specific request of H/Cell, or
the failure to take any actions due to the restrictions set forth in this Agreement; except, with respect to clauses (a), (b),
(c), (f) or (g), so long as such changes do not have a disproportionate adverse impact on Pride, taken as a whole, relative to
other businesses of similar size operating in the same industry in which Pride operates.


 




    	 	- 18 -	 



     


    

 


“Consent”
means any consent, approval, authorization, permit, clearances, exemption and notice.


 


“Contracts” means
any contracts, agreements, licenses, notes, bonds, mortgages, deeds, undertakings, indentures, leases or other binding instruments
or binding commitments, whether written or oral.


 


“Employee
Program” means (a) all employee share or benefit plans within the meaning of Division 13 of the Income Tax
Assessment Act 1997 (Cth), including, but not limited to multiple employer welfare arrangements, plans to which more than one unaffiliated
employer contributes, and employee benefit plans (such as foreign or excess benefit plans) which do not qualify under the aforementioned
Division 13; and (b) all share and stock option plans, bonus or incentive award plans, severance pay policies or agreements, deferred
compensation agreements, supplemental income arrangements, vacation plans, and all other employee benefit plans, agreements, and
arrangements not described in (a) above.


 


“Environmental
Law” means any Law regulating or relating to the protection of human health, safety, natural resources or
the environment.


 


“Exchange
Act” means the Securities Exchange Act of 1934, as amended.


 


“GAAP”
means generally accepted accounting principles in the United States in effect from time to time.


 


“Governmental
Entity” means any international, national, federal, state, provincial or local governmental, regulatory or administrative
authority, agency, commission, court, tribunal, arbitral body, self-regulated entity or similar body, whether domestic or foreign.


 


“Hazardous
Substance” shall mean (a) any material, substance, chemical, waste, product, derivative, compound, mixture,
solid, liquid, mineral or gas, in each case, whether naturally occurring or manmade, that is hazardous, acutely hazardous, toxic,
or words of similar import or regulatory effect under Environmental Laws, and (b) any petroleum or petroleum-derived products,
radon, radioactive materials or wastes, asbestos in any form, lead or lead-containing materials, urea formaldehyde foam insulation
and polychlorinated biphenyls.


 




    	 	- 19 -	 



     


    

 


“H/Cell Material
Adverse Effect” means a material adverse effect on the ability of H/Cell to perform its obligations under this Agreement
or on the ability of H/Cell to consummate the Acquisition and the other transactions contemplated hereby.


 


“H/Cell’s
Knowledge” or “Knowledge of H/Cell” means the actual knowledge of the officers or directors of H/Cell.


 


“Intellectual
Property” means all intellectual property and other similar proprietary rights in any jurisdiction, whether
owned or held for use under license, whether registered or unregistered, including such rights in and to: (a) patents and applications
therefor and all reissues, divisions, renewals, extensions, provisionals, continuations and continuations-in-part thereof, continuing
patent applications, reexaminations, and extensions thereof, any counterparts claiming priority therefrom, utility models, patents
of importation/confirmation, certificates of invention, certificates of registration and like rights (“Patents”);
inventions, invention disclosures, discoveries and improvements, whether or not patentable; (b) copyrights and all other similar
rights throughout the world; (c) design rights; (d) trade names, logos, trademarks and service marks, trade dress, certification
marks and the goodwill associated with the foregoing; (e) trade secrets (including, those trade secrets defined in the Uniform
Trade Secrets Act or under similar foreign statutory and common law), business, technical and know-how information, databases,
data collections and other confidential and proprietary information and all rights therein; (f) software, including data files,
source code, object code, application programming interfaces, architecture, documentation, files, records, schematics, computerized
databases and other software-related specifications and documentation; and (g) Internet domain names; and in each case of (a) to
(g) above, including any registrations of, applications to register, and renewals and extensions of, any of the foregoing with
or by any Governmental Entity in any jurisdiction.


 


“Laws” means
any domestic or foreign laws, common law, statutes, ordinances, rules, regulations, codes, Orders or legally enforceable requirements
enacted, issued, adopted, promulgated, enforced, ordered or applied by any Governmental Entity.


 


“Liens” means,
with respect to any property or asset, all pledges, liens, mortgages, charges, encumbrances, hypothecations, options, rights of
first refusal, rights of first offer and security interests of any kind or nature whatsoever.


 


“Litigation”
means any action, cause of action, claim, cease and desist letter, demand, suit, arbitration proceeding, citation, summons, subpoena
or investigation or proceeding of any nature, civil, criminal, regulatory or otherwise, at law or in equity.


 


“Order” means
order, writ, assessment, decision, injunction, decree, ruling or judgment of a Governmental Entity.


 


“Organizational
Documents” means the articles of incorporation, certificate of incorporation, charter, bylaws, articles of formation,
certificate of formation, regulations, operating agreement, certificate of limited partnership, partnership agreement, and all
other similar documents, instruments or certificates executed, adopted, or filed in connection with the creation, formation, or
organization of a Person, including any amendments thereto.




    	 	- 20 -	 



     


    

 


“Party”
means any of H/Cell, Pride or the Pride Shareholders, and “Parties” means both of them collectively.


 


“Permitted
Liens” means (a) statutory Liens for current Taxes or other governmental charges or assessments not yet due
and payable or the amount or validity of which is being contested in good faith (provided appropriate reserves required pursuant
to GAAP have been made in respect thereof), (b) mechanics’, carriers’, workers’, repairers’ and similar
statutory Liens arising or incurred in the ordinary course of business for amounts which are not delinquent or which are being
contested by appropriate proceedings (provided appropriate reserves required pursuant to GAAP have been made in respect thereof),
(c) zoning, entitlement, building and other land use regulations imposed by Governmental Entities having jurisdiction over such
Person’s owned or leased real property, which are not violated by the current use and operation of such real property, (d)
covenants, conditions, restrictions, easements and other similar non-monetary matters of record affecting title to such Person’s
owned or leased real property, which do not materially impair the occupancy or use of such real property for the purposes for which
it is currently used in connection with such Person’s businesses, (e) any right of way or easement related to public roads
and highways, and (f) Liens arising under workers’ compensation, unemployment insurance, social security, retirement and
similar legislation.


 


“Permits”
means any material certificates, licenses, permits, authorizations and approvals required by Law in connection with the operation
of the business of either company as presently conducted.


 


“Person” means
any individual, corporation, limited or general partnership, limited liability company, limited liability partnership, trust, association,
joint venture, Governmental Entity and other entity and group (which term will include a “group” as such term is defined
in Section 13(d)(3) of the Exchange Act).


 


“Pride Shareholders’
Knowledge” or “Knowledge of the Pride Shareholders” means the actual knowledge of the officers, directors
or principals of either Seller.


 


“Release”
means any releasing, disposing, discharging, injecting, spilling, leaking, leaching, pumping, dumping, emitting, escaping, emptying,
seeping, dispersal, migration, transporting, placing and the like, including without limitation, the moving of any materials through,
into or upon, any land, soil, surface water, groundwater or air, or otherwise entering into the indoor or outdoor environment.


 


“SEC” means
the Securities and Exchange Commission.


 


“Securities
Act” means the Securities Act of 1933, as amended.


 


“Subsidiary”
means, when used with respect to any party, any corporation or other organization, whether incorporated or unincorporated, a majority
of the securities or other interests of which having by their terms ordinary voting power to elect a majority of the board of directors
or others performing similar functions with respect to such corporation or other organization is directly or indirectly owned or
controlled by such party or by any one or more of its subsidiaries, or by such party and one or more of its subsidiaries.


 




    	 	- 21 -	 



     


    

 


“Taxes”
means all federal, state, local, foreign and other income, gross receipts, sales, use, production, ad valorem, transfer, franchise,
registration, profits, license, lease, service, service use, withholding, payroll, employment, unemployment, estimated, excise,
severance, environmental, stamp, occupation, premium, property (real or personal), real property gains, windfall profits, customs,
duties or other taxes, fees, assessments or charges of any kind whatsoever, together with any interest, additions or penalties
with respect thereto and any interest in respect of such additions or penalties.


 


“Tax
Returns” means any return, declaration, report, claim for refund, information return or statement or other
document required to be filed with or provided to any taxing authority in respect of Taxes, including any schedule or attachment
thereto, and including any amendment thereof.


 


Index of Defined
Terms.


 


	Defined Term	 	Section	 	Page
	 	 	 	 	 
	Agreement	 	Preamble	 	1
	 	 	 	 	 
	Acquisition	 	1.01(d)	 	2
	 	 	 	 	 
	Acquisition Shares	 	1.01(a)	 	1
	 	 	 	 	 
	Balance Sheet	 	2.08	 	5
	 	 	 	 	 
	Balance Sheet Date	 	2.08	 	5
	 	 	 	 	 
	Benefit Plans	 	2.15(b)	 	7
	 	 	 	 	 
	Closing	 	1.02	 	2
	 	 	 	 	 
	Closing Date	 	1.02	 	2
	 	 	 	 	 
	Effect	 	Definition of “Pride Material Adverse Effect”	 	15
	 	 	 	 	 
	Escrow Agreement	 	1.01(c)	 	2
	 	 	 	 	 
	Escrowed Shares	 	1.01(c)	 	2
	 	 	 	 	 
	Fairness Opinion	 	4.03	 	11
	 	 	 	 	 
	Financial Statements	 	2.08	 	5
	 	 	 	 	 
	GAAP	 	2.08	 	5


 




    	 	- 22 -	 



     


    

 


	H/Cell	 	Preamble	 	1
	 	 	 	 	 
	H/Cell Indemnified Persons	 	4.08(b)	 	12
	 	 	 	 	 
	Independent Accounting Firm	 	1.01(b)	 	1
	 	 	 	 	 
	Leased Real Property	 	2.16	 	7
	 	 	 	 	 
	Leases	 	2.16	 	7
	 	 	 	 	 
	Material Consent	 	4.03	 	11
	 	 	 	 	 
	Material Contract	 	2.16	 	8
	 	 	 	 	 
	NTAV	 	1.01(b)	 	1
	 	 	 	 	 
	Pride	 	Preamble	 	1
	 	 	 	 	 
	Pride Disclosure Letter	 	Article II	 	3
	 	 	 	 	 
	Pride Shareholders	 	Preamble	 	1
	 	 	 	 	 
	Securities Act	 	3.04	 	10
	 	 	 	 	 
	Shares	 	Preamble	 	1


 


Section
7.08. Counterparts. This Agreement may be executed in one or more counterparts, all of which shall be considered
one and the same agreement, and shall become effective when one or more such counterparts have been signed by each of the Parties
and delivered to the other Parties. In the event that any signature is delivered by facsimile transmission or by an e-mail which
contains a portable document format (.pdf) file of an executed signature page, such signature page shall create a valid and binding
obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature
page were an original thereof.


 


Section
7.09. Entire Agreement; Survival. This Agreement (including the Exhibits to this Agreement) and the Pride Disclosure
Letter constitute the entire agreement among the Parties with respect to the subject matter of this Agreement and supersede all
other prior agreements and understandings, both written and oral, among the parties to this Agreement with respect to the subject
matter of this Agreement. In the event of any inconsistency between the statements in the body of this Agreement and the Pride
Disclosure Letter (other than an exception expressly set forth as such in the Pride Disclosure Letter), the statements in the body
of this Agreement will control.


 




    	 	- 23 -	 



     


    

 


Section
7.10. Severability. If any term or provision of this Agreement is invalid, illegal or unenforceable in any jurisdiction,
such invalidity, illegality or unenforceability shall not affect any other term or provision of this Agreement or invalidate or
render unenforceable such term or provision in any other jurisdiction. Upon such determination that any term or other provision
is invalid, illegal or unenforceable, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect
the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated
hereby be consummated as originally contemplated to the greatest extent possible.


 


Section
7.11. Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the
State of Nevada without giving effect to any choice or conflict of law provision or rule (whether of the State of Nevada or any
other jurisdiction) that would cause the application of Laws of any jurisdiction other than those of the State of Nevada.


 


Section
7.12. Waiver of Jury Trial. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT
IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY
RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL ACTION ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED BY THIS AGREEMENT. EACH PARTY TO THIS AGREEMENT CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE OF ANY OTHER
PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT SEEK TO ENFORCE THE FOREGOING WAIVER IN THE EVENT
OF A LEGAL ACTION, (B) SUCH PARTY HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C) SUCH PARTY MAKES THIS WAIVER VOLUNTARILY,
AND (D) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS
IN THIS SECTION 7.12.


 


Section
7.13. Consent to Jurisdiction. Each Party hereby irrevocably and unconditionally submits, for itself and its property,
to the exclusive jurisdiction of the United States District Court for the Southern District of New York, or, if (and only if) such
court lacks subject matter jurisdiction, the Federal court of the United States of America sitting in New York, and any appellate
court from any thereof, in any action or proceeding arising out of or relating to this Agreement or the agreements delivered in
connection herewith or the transactions contemplated hereby or thereby or for recognition or enforcement of any judgment relating
thereto, and each of the parties hereby irrevocably and unconditionally (a) agrees not to commence any such action or proceeding
except in the United States District Court for the Southern District of New York, or, if (and only if) such court lacks subject
matter jurisdiction, the Federal court of the United States of America sitting in New York, and any appellate court from any thereof,
(b) agrees that any claim in respect of any such action or proceeding may be heard and determined in the United States District
Court for the Southern District of New York, or, if (and only if) such court lacks subject matter jurisdiction, the Federal court
of the United States of America sitting in New York, and any appellate court from any thereof, (c) waives, to the fullest extent
it may legally and effectively do so, any objection that it may now or hereafter have to the laying of venue of any such action
or proceeding in the United States District Court for the Southern District of New York, or, if (and only if) such court lacks
subject matter jurisdiction, the Federal court of the United States of America sitting in New York, and any appellate court from
any thereof and (d) waives, to the fullest extent permitted by Law, the defense of an inconvenient forum to the maintenance of
such action or proceeding in the United States District Court for the Southern District of New York, or, if (and only if) such
court lacks subject matter jurisdiction, the Federal court of the United States of America sitting in New York, and any appellate
court from any thereof. Each Party agrees that a final judgment in any such action or proceeding shall be conclusive and may be
enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. Each party to this Agreement irrevocably
consents to service of process in the manner provided for notices in Section 7.13. Nothing in this Agreement will affect
the right of any party to this Agreement to serve process in any other manner permitted by Law.


 




    	 	- 24 -	 



     


    

 


Section
7.14. Separate Counsel. Each Party hereby expressly acknowledges that
it has been advised to seek its own separate legal counsel for advice with respect to this Agreement, and that no counsel to any
Party hereto has acted or is acting as counsel to any other Party hereto in connection with this Agreement.


 


[signature page follows]


 




    	 	- 25 -	 



     


    

 


IN WITNESS WHEREOF, the
Pride Shareholders, Pride and H/Cell have duly executed this Agreement as of the date first written above.


 


	 	H/CELL ENERGY CORPORATION
	 	 
	 	By:	 
	 	 	Name: Matthew Hidalgo
	 	 	Title: Chief Financial Officer
	 	 
	 	THE PRIDE GROUP (QLD) PTY LTD
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:
	 	 
	 	TURQUINO EQUITY LLC
	 	 
	 	By:	 
	 	 	Name: Andrew Hidalgo
	 	 	Title: Managing Member
	 	 
	 	STEPHEN PAUL MULLANE AND MARIE LOUISE MULLANE AS TRUSTEES OF THE MULLANE FAMILY TRUST
	 	 
	 	By:	 
	 	 	Name: Stephen Mullane
	 	 	Title:  Trustee


 


Signature Page to Share Exchange Agreement 


 




     


     


    

 


ANNEX I


 


	(I)	 	(II)	 	 	(III)	 	 	(IV)	 	 	(V)	 
	Name of Pride Shareholder	 	Shares of
 Pride Class A
 Common to be
 Transferred to
 H/Cell	 	 	Total Shares
 of H/Cell
 Common
 Stock to be
 Received	 	 	Shares of
 H/Cell
 Common Stock
 to be Received
 at Closing	 	 	Shares of H/Cell
 Common Stock
 to be Held in
 Escrow Pending
 NTAV	 
	Turquino Equity LLC	 	 	78,351	 	 	 	3,040,000	 	 	 	2,736,000	 	 	 	304,000	 
	Stephen Paul Mullane and Marie Louise Mullane as Trustees of the Mullane Family Trust	 	 	19,588	 	 	 	760,000	 	 	 	684,000	 	 	 	76,000	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Total:	 	 	97,939	 	 	 	3,800,000	 	 	 	3,420,000	 	 	 	380,000